M&A

Shire Completes Acquisition of Dyax
Yahoo
Fri, 01/22/16 - 10:06 am
Shire
Dyax
M&A
How Shire can Fuel Another Pfizer-Allergan Type Deal
Bidness, ETC
Thu, 01/21/16 - 05:43 pm
Shire
M&A
Pfizer
Allergan
Baxalta
tax inversions
Drugmaker Medicines Co. Is Said to Explore a Sale
Bloomberg
Thu, 01/21/16 - 10:00 am
Medicines Company
M&A
Actelion CEO dismisses talk of Basilea buyout bid
Fierce Biotech
Wed, 01/20/16 - 09:38 pm
Actelion
Basilea
M&A
Ipsen to Step Up Deal-Making, Scout for New Cancer Products
Bloomberg
Tue, 01/19/16 - 04:27 pm
Ipsen
M&A
oncology
Ariad preps for a sale, but new chairman says it may take time
Bizjournals.com
Tue, 01/19/16 - 08:24 am
Ariad Pharma
M&A
Acorda bags PhIII Parkinson's drug in $363M Biotie buyout
Fierce Biotech
Tue, 01/19/16 - 08:20 am
Acorda Therapeutics
Parkinson's Disease
BioTie Therapies
M&A
tozadenant
Shire-Baxalta Inc Deal: Benefits Outweigh Risks
Bidness, ETC
Tue, 01/19/16 - 08:13 am
Shire
Baxalta
M&A
Shire, Baxalta Merger is Now Street-Approved: Here’s Why
Bidness, ETC
Sat, 01/16/16 - 11:29 am
Shire
Baxalta
M&A
Juno Buyout Puts Single-Cell Sequencing In Spotlight
Investors.com
Sat, 01/16/16 - 11:26 am
Juno Therapeutics
M&A
Celgene
AbVitro
single-cell sequencing
Johnson & Johnson Uninterested in Pfizer-Allergan Type Mergers
Bidness, ETC
Fri, 01/15/16 - 02:25 pm
JNJ
M&A
Pfizer expands consumer biz in China with Treerly supplements buy
Fierce Pharma
Fri, 01/15/16 - 07:07 am
Pfizer
China
M&A
Treerly
J&J CEO Prefers Smaller Acquisitions Even as Cash Pile Grows
Bloomberg
Thu, 01/14/16 - 10:17 am
JNJ
Pharma CEOs
M&A
Alex Gorsky
Shire CEO thinks he can beat $500M in postmerger cost savings
Fierce Pharma
Thu, 01/14/16 - 10:13 am
Shire
Pharma CEOs
Flemming Ornskov
Baxalta
M&A
Depomed isn't anti-takeover, CEO says. It was just anti-Horizon
Fierce Pharma
Thu, 01/14/16 - 09:53 am
Depomed
Horizon Pharma
M&A
Jim Schoeneck
Pfizer CEO: Allergan deal is 'a lot more about growth' than job cuts
Fierce Pharma
Wed, 01/13/16 - 04:13 pm
Pfizer
Pharma CEOs
Allergan
M&A
Ian Read
layoffs
Shire's Baxalta Acquisition: An Orphan Drugs Market Dream?
Forbes
Wed, 01/13/16 - 10:45 am
Shire
Baxalta
M&A
orphan drugs
Shire says internal synergy goals from Baxalta deal higher
Yahoo/Reuters
Tue, 01/12/16 - 09:16 pm
Shire
Baxalta
M&A
Now focused on integrating Allergan generics, Teva eyes 'much larger' specialty buy in 2017
Fierce Pharma
Tue, 01/12/16 - 02:38 pm
Allergan
Teva Pharmaceutical
generics
M&A
Erez Vigodman
3 Things You Absolutely Must Know About Merck
Motley Fool
Tue, 01/12/16 - 02:30 pm
Merck
M&A
Keytruda
elbasvir/grazoprevir
Kenneth Frazier

Pages